Holen Sie sich die Stockscreener-App
22.62
4.19%
0.91
Finanzdaten der Alto Neuroscience Inc-Aktie (ANRO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-07-01 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
7.34%
29.13
|
27.14 | 17.05 | 14.95 | 18.68 |
| Operating Income/Loss |
7.34%
-29.13
|
-27.14 | -17.05 | -14.95 | -18.68 |
| Nonoperating Income/Loss |
65.48%
1.491
|
0.901 | 0.873 | 0.77 | 0.976 |
| Net Income/Loss |
5.34%
-27.64
|
-26.24 | -16.18 | -14.18 | -17.71 |
| Basic Average Shares |
30.16%
42.81
|
32.89 | - | 27.10 | 27.07 |
| Diluted Average Shares |
30.16%
42.81
|
32.89 | - | 27.10 | 27.07 |
| Basic Earnings Per Share |
18.75%
-0.65
|
-0.80 | - | -0.52 | -0.65 |
| Diluted Earnings Per Share |
18.75%
-0.65
|
-0.80 | - | -0.52 | -0.65 |
2.91%
0.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):